In particular, the canonical EMT-related E- to N-cadherin switch is unlikely to be a central process in these neoplastic diseases and the assumption that N-cadherin expression marks for such a mesenchymal phenotype is likely farfetched. Here, CDH2 is linked to neoplasm.